COVID-19: The multi-billion pound business of the Oxford vaccine

The Oxford University-AstraZeneca vaccine is a collaboration between a pharmaceutical giant and an ancient institution aiming to become as adept at monetising its discoveries as it is at making them.

The full article is no longer available.